CTOs on the Move

Hyalex Orthopaedics

www.hyalex.com

 
Hyalex Orthopaedics is a venture backed Boston-based medical device start-up focused on developing and commercializing new products that feature HYALEX™ materials technology.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.hyalex.com
  • 99 Hayden Ave. Suite 340, Building D
    Lexington, MA USA 02421
  • Phone: 781.778.3232

Executives

Name Title Contact Details

Funding

Hyalex Orthopaedics raised $17M on 03/28/2019

Similar Companies

Scrubs and Beyond

Scrubs and Beyond is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Internal Medical Group

Internal Medical Group is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Synapse Information Resources

Synapse Information Resources is a Endicott, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Senior Care Services

Senior Care Services is a Grand Junction, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novadaq

Enabling surgeons with clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing health care costs, is Novadaq’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to harmful ionizing radiation or contrast dye toxicity. More than 130 peer-reviewed publications demonstrate that the use of SPY during complex surgery, leads to fewer post-operative complications and lower hospital costs. The SPY Imaging System is United States Food and Drug Administration (“FDA”) 510(k) cleared for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT®, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. Our unique business model of partnering with market-leading companies to drive adoption of our fluorescence imaging technology, while building our own commercial infrastructure is the cornerstone of our corporate strategy for growth.